Mirae Asset Global Investments Co. Ltd. Has $9.61 Million Position in Aflac Incorporated (NYSE:AFL)

Mirae Asset Global Investments Co. Ltd. increased its stake in Aflac Incorporated (NYSE:AFLGet Rating) by 6.2% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 149,238 shares of the financial services provider’s stock after purchasing an additional 8,665 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Aflac were worth $9,609,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Cerro Pacific Wealth Advisors LLC grew its holdings in shares of Aflac by 1.4% during the first quarter. Cerro Pacific Wealth Advisors LLC now owns 12,350 shares of the financial services provider’s stock worth $795,000 after buying an additional 174 shares in the last quarter. BOKF NA grew its holdings in shares of Aflac by 0.6% during the fourth quarter. BOKF NA now owns 33,105 shares of the financial services provider’s stock worth $1,933,000 after buying an additional 186 shares in the last quarter. Kinneret Advisory LLC grew its holdings in shares of Aflac by 2.3% during the first quarter. Kinneret Advisory LLC now owns 8,441 shares of the financial services provider’s stock worth $544,000 after buying an additional 190 shares in the last quarter. Crawford Investment Counsel Inc. grew its holdings in shares of Aflac by 1.0% during the first quarter. Crawford Investment Counsel Inc. now owns 19,178 shares of the financial services provider’s stock worth $1,235,000 after buying an additional 192 shares in the last quarter. Finally, Aviance Capital Partners LLC grew its holdings in shares of Aflac by 5.1% during the first quarter. Aviance Capital Partners LLC now owns 4,092 shares of the financial services provider’s stock worth $263,000 after buying an additional 200 shares in the last quarter. 66.32% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Barbara K. Rimer sold 11,026 shares of the company’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $58.49, for a total value of $644,910.74. Following the completion of the transaction, the director now owns 33,413 shares of the company’s stock, valued at $1,954,326.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Aflac news, Director Barbara K. Rimer sold 11,026 shares of the stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $58.49, for a total transaction of $644,910.74. Following the completion of the sale, the director now owns 33,413 shares of the company’s stock, valued at approximately $1,954,326.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Teresa L. White sold 10,000 shares of the stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $59.24, for a total transaction of $592,400.00. Following the sale, the insider now directly owns 134,256 shares of the company’s stock, valued at approximately $7,953,325.44. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 38,272 shares of company stock valued at $2,338,959. 1.10% of the stock is currently owned by corporate insiders.

Aflac Stock Performance

AFL opened at $60.53 on Wednesday. Aflac Incorporated has a 12-month low of $51.28 and a 12-month high of $67.20. The stock has a market cap of $38.25 billion, a price-to-earnings ratio of 9.13, a PEG ratio of 2.22 and a beta of 0.91. The business has a 50 day moving average of $59.38 and a 200-day moving average of $59.54. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.28.

Aflac (NYSE:AFLGet Rating) last released its quarterly earnings data on Monday, August 1st. The financial services provider reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.27. Aflac had a return on equity of 12.40% and a net margin of 20.37%. The company had revenue of $5.40 billion during the quarter, compared to analysts’ expectations of $4.79 billion. During the same period last year, the firm posted $1.59 earnings per share. The business’s revenue was down 2.9% on a year-over-year basis. On average, equities research analysts expect that Aflac Incorporated will post 5.37 earnings per share for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 1st. Investors of record on Wednesday, August 24th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Tuesday, August 23rd. This represents a $1.60 annualized dividend and a yield of 2.64%. Aflac’s dividend payout ratio is 24.13%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Evercore ISI decreased their price objective on Aflac from $60.00 to $59.00 and set an “in-line” rating for the company in a report on Wednesday, July 6th. Morgan Stanley raised their price target on Aflac from $66.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, August 17th. JPMorgan Chase & Co. raised their price target on Aflac from $61.00 to $62.00 in a research note on Monday, July 11th. Finally, Piper Sandler decreased their price target on Aflac from $68.00 to $66.00 and set an “overweight” rating for the company in a research note on Friday, July 8th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $62.17.

Aflac Profile

(Get Rating)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLGet Rating).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.